<DOC>
	<DOC>NCT01390805</DOC>
	<brief_summary>The purpose of this study is to collect and assess information on proper use of valaciclovir regarding safety and efficacy of long-term use in suppressive therapy for subjects with recurrent genital herpes.</brief_summary>
	<brief_title>Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)</brief_title>
	<detailed_description />
	<mesh_term>Herpes Genitalis</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Subjects who started suppressive therapy for recurrent genital herpes for the first time Subjects with a history of hypersensitivity to the ingredients of VALTREX or aciclovir</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>